论文部分内容阅读
目的探讨低分子肝素钙治疗慢性阻塞性肺疾病急性加重期(AECOPD)的临床疗效。方法选取本院收治的AECOPD患者78例进行分析,按照治疗方法分成观察组和对照组各39例,观察组在常规治疗基础上加用低分子肝素钙,对照组仅采用常规治疗,观察两组临床疗效及治疗前后血气指标变化。结果观察组治疗总有效率明显高于对照组(P<0.05);两组治疗后血气指标均有明显改善(P<0.05),且观察组改善水平明显优于对照组(P<0.05)。结论低分子肝素钙治疗AECOPD患者能够有效缓解患者的临床症状,改善血气指标,安全有效。
Objective To investigate the clinical efficacy of low molecular weight heparin in the treatment of acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Methods AECOPD patients admitted to our hospital were analyzed in 78 cases. According to the treatment, 39 cases were divided into observation group and control group. The observation group received low molecular weight heparin calcium on the basis of routine treatment. The control group was treated with conventional therapy only. Clinical efficacy and blood gas changes before and after treatment. Results The total effective rate of the observation group was significantly higher than that of the control group (P <0.05). The blood gas indexes of the two groups were significantly improved (P <0.05), and the improvement of the observation group was obviously better than that of the control group (P <0.05). Conclusion Low molecular weight heparin treatment of AECOPD patients can effectively alleviate the clinical symptoms of patients, improve blood gas indicators, safe and effective.